Importance: Use of low-dose aspirin for the primary prevention of cardiovascular events remains controversial because increased risk of bleeding may offset the overall benefit. Among major bleeding events, intracranial hemorrhage is associated with high mortality rates and functional dependency.
Objective: To assess the risk of intracranial hemorrhage associated with low-dose aspirin among individuals without symptomatic cardiovascular disease.
Data sources: PubMed, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were searched from January 1966 to October 30, 2018.
Study selection: Randomized clinical trials that compared low-dose aspirin (daily dose ≤100 mg) vs control and recorded the end points of intracranial hemorrhage separately for active treatment and control groups were included.
Data extraction and synthesis: A random-effect estimate was computed based on the Mantel-Haenszel method. Relative risk with 95% CI was used as a measure of aspirin vs control on risk of intracranial hemorrhage.
Main outcomes and measures: The main outcomes were any intracranial hemorrhage, intracerebral hemorrhage, subdural or extradural hemorrhage, and subarachnoid hemorrhage, for aspirin vs control.
Results: The search identified 13 randomized clinical trials of low-dose aspirin use for primary prevention, enrolling 134 446 patients. Pooling the results from the random-effects model showed that low-dose aspirin, compared with control, was associated with an increased risk of any intracranial bleeding (8 trials; relative risk, 1.37; 95% CI, 1.13-1.66; 2 additional intracranial hemorrhages in 1000 people), with potentially the greatest relative risk increase for subdural or extradural hemorrhage (4 trials; relative risk, 1.53; 95% CI, 1.08-2.18) and less for intracerebral hemorrhage and subarachnoid hemorrhage. Patient baseline features associated with heightened risk of intracerebral hemorrhage with low-dose aspirin, compared with control, were Asian race/ethnicity and low body mass index.
Conclusions and relevance: Among people without symptomatic cardiovascular disease, use of low-dose aspirin was associated with an overall increased risk of intracranial hemorrhage, and heightened risk of intracerebral hemorrhage for those of Asian race/ethnicity or people with a low body mass index.
Conflict of interest statement
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.JAMA Neurol. 2018 Dec 1;75(12):1511-1518. doi: 10.1001/jamaneurol.2018.2215. JAMA Neurol. 2018. PMID: 30105396 Free PMC article.
Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep. Report No.: 13-05193-EF-1. Agency for Healthcare Research and Quality (US). 2015. PMID: 26491756 Free Books & Documents. Review.
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Agency for Healthcare Research and Quality (US). 2014. PMID: 24783270 Free Books & Documents. Review.
Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.JAMA. 2019 Jan 22;321(3):277-287. doi: 10.1001/jama.2018.20578. JAMA. 2019. PMID: 30667501 Free PMC article.
Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep. Report No.: 15-05228-EF-1. Agency for Healthcare Research and Quality (US). 2015. PMID: 26491758 Free Books & Documents. Review.
Cited by 6 articles
Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events.CMAJ. 2020 Mar 23;192(12):E302-E311. doi: 10.1503/cmaj.191599. CMAJ. 2020. PMID: 32392513 Free PMC article. No abstract available.
Differences in omega-5-gliadin allergy: East versus West.Asia Pac Allergy. 2020 Jan 26;10(1):e5. doi: 10.5415/apallergy.2020.10.e5. eCollection 2020 Jan. Asia Pac Allergy. 2020. PMID: 32099827 Free PMC article.
Antithrombotic Management After Intracranial Hemorrhage.Curr Treat Options Cardiovasc Med. 2019 Dec 10;21(12):88. doi: 10.1007/s11936-019-0771-y. Curr Treat Options Cardiovasc Med. 2019. PMID: 31823078 Review.
Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea.Drugs Aging. 2020 Jan;37(1):43-55. doi: 10.1007/s40266-019-00723-3. Drugs Aging. 2020. PMID: 31755069
The death of aspirin for primary prevention-should aspirin be changed to a prescription only medication?Ann Transl Med. 2019 Sep;7(17):402. doi: 10.21037/atm.2019.07.05. Ann Transl Med. 2019. PMID: 31660301 Free PMC article. No abstract available.